Related Experiment Video
Updated: Jul 9, 2025

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
Application Potential of Extracellular Vesicles Derived From Mesenchymal Stem Cells in Renal Diseases
1Department of Nephrology, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Abstract:
The high prevalence and complex etiology of renal diseases already impose a heavy disease burden on patients and society. In certain kidney diseases such as acute kidney injury and chronic kidney disease, current treatments are limited to slowing rather than stabilizing or reversing disease progression. Therefore, it is crucial to study the pathological mechanisms of kidney disease and discover new therapeutic targets and effective therapeutic drugs. As cell-free therapeutic strategies are continually being developed, extracellular vesicles derived from mesenchymal stem cells (MSC-EVs) have emerged as a hot topic for research in the field of renal diseases. Studies have demonstrated that MSC-EVs not only reproduce the therapeutic effects of MSCs but also localize to damaged kidney tissue. Compared to MSCs, MSC-EVs have several advantages, including ease of preservation, low immunogenicity, an inability to directly form tumors, and ease of artificial modification. Exploring the detailed mechanisms of MSC-EVs by developing standardized culture, isolation, purification, and drug delivery strategies will help facilitate their clinical application in kidney diseases. Here, we provide a comprehensive overview of studies about MSC-EVs in kidney diseases and discuss their limitations at the human nephrology level.
Insights
Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) show promise for treating kidney diseases, offering advantages over stem cells. Further research into MSC-EVs is vital for clinical applications in nephrology.
Area of Science:
- Nephrology
- Regenerative Medicine
- Biotechnology
Background:
- Renal diseases present a significant global health burden with limited treatment options.
- Current therapies for kidney diseases like acute kidney injury and chronic kidney disease primarily slow progression, rather than reverse damage.
- There is a critical need to understand kidney disease mechanisms and identify novel therapeutic targets and drugs.
Purpose of the Study:
- To provide a comprehensive overview of mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) in the context of kidney diseases.
- To discuss the potential of MSC-EVs as a cell-free therapeutic strategy for renal pathologies.
- To highlight the advantages of MSC-EVs over mesenchymal stem cells (MSCs) for therapeutic applications.
Main Methods:
- Review of existing scientific literature on MSC-EVs and their application in kidney diseases.
- Analysis of studies demonstrating the therapeutic effects and tissue localization of MSC-EVs.
- Discussion of the comparative benefits of MSC-EVs, including preservation, immunogenicity, and modification.
Main Results:
- MSC-EVs replicate the therapeutic benefits of MSCs and target damaged kidney tissue.
- MSC-EVs possess advantages such as ease of preservation, low immunogenicity, and reduced tumor formation risk compared to MSCs.
- Standardized methods for MSC-EV culture, isolation, purification, and drug delivery are crucial for clinical translation.
Conclusions:
- MSC-EVs represent a promising cell-free therapeutic approach for various kidney diseases.
- Further development of standardized protocols is essential to advance the clinical application of MSC-EVs in nephrology.
- Understanding the detailed mechanisms and overcoming limitations of MSC-EVs will facilitate their use in treating renal diseases.
Related Concept Videos
Mesenchymal Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

